APA
Estaire Gómez, Mercedes & Cerdán¿Santacruz, C. & Cano Valderrama, Ó. & Peña Ros, E. & Serrano del Moral, Á. & Pereira Pérez, F. & Flor Lorente, B. & Biondo, S. & Collaborating group for the study of metachronous peritoneal metastases of pT4 colon cancer (2023-05 ) .Epidemiology, oncologic results and risk stratifcation model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long¿term follow¿up study.
ISO 690
Estaire Gómez, Mercedes & Cerdán¿Santacruz, C. & Cano Valderrama, Ó. & Peña Ros, E. & Serrano del Moral, Á. & Pereira Pérez, F. & Flor Lorente, B. & Biondo, S. & Collaborating group for the study of metachronous peritoneal metastases of pT4 colon cancer. 2023-05 .Epidemiology, oncologic results and risk stratifcation model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long¿term follow¿up study.
https://hdl.handle.net/20.500.12080/39624
Resumen:
Purpose Metachronous peritoneal metastases (MPM) following a curative surgery procedure for pT4 colon cancer is a chal lenging condition. Current epidemiological studies on this topic are scarce.
Methods A retrospective multicentre trial was designed. All consecutive patients who underwent operations to treat pT4
cancers between 2015 and 2017 were reviewed. Demographic, clinical, operative, pathological and oncological follow-up
variables were included. MPM were described as any oncological disease at the peritoneum, clearly diferent from a local
recurrence. Univariate and multivariate Cox regression models were constructed. A risk stratifcation model was created on
a cumulative factor basis. According to the calculated hazard ratio (HR), a scoring system was designed (HR<3, 1 point;
HR>3, 2 points) and a scale from 0 to 6 was calculated for peritoneal disease-free rate (PDF-R). A risk stratifcation model
was also created on the basis of these calculations.
Results Fifty diferent hospitals were involved, which included a total of 1356 patients. Incidence of MPM was 13.6% at
50 months median follow-up. The strongest independent risk factors for MPM were positive pN stage [HR 3.72 (95% CI
2.56¿5.41; p<0.01) for stage III disease], tumour perforation [HR 1.91 (95% CI 1.26¿2.87; p<0.01)], mucinous or signet
ring cell histology [HR 1.68 (95% CI 1.1¿2.58; p=0.02)], poorly diferentiated tumours [HR 1.54 (95% CI 1.1¿2.2; p=0.02)]
and emergency surgery [HR 1.42 (95% CI 1.01¿2.01; p=0.049)]. In the absence of additional risk factors, pT4 tumours
showed 98% and 96% PDF-R in 1-year and 5-year periods based on Kaplan¿Meier curves.
Conclusions Cumulative MPM incidence was 13.6% at 5-year follow-up. The sole presence of a pT4 tumour resulted in high
rates of PDF-R at 1-year and 5-year follow-up (98% and 96% respectively). Five additional risk factors diferent from pT4
status itself were identifed as possible MPM indicators during follow-up.
Keywords Colon cancer · Metachronous peritoneal metastases · Second look · HIPEC · Risk stratifcation